IBM Watson

By MobiHealthNews August 13, 2018
Bankrupting docs? Patient booking platform Zocdoc is putting providers in a sticky situation, CNBC reports. The platform, which lets patients book and cancel appointments, is changing its business model. Now instead of charging providers a flat annual rate per doctor, it proposes to charge a lower annual rate as well as a booking fee for each new customer. Not only would this dramatically...
By Laura Lovett June 25, 2018
Two years after originally announcing it, Medtronic and IBM Watson have launched their joint platform the Sugar.IQ, a digital diabetes assistant.  “It is designed for people who are currently using Guardian Connect; so made for people on multiple daily injections. It is a personal assistant a little bit like Alexa or Siri,” Huzefa Neemuchwala, global head of digital health solutions and AI at...
By Laura Lovett March 8, 2018
The Mayo Clinic has just released the results of a new study, which show an 80 percent increase in enrollment of clinical trials for breast cancer when using IBM’s Watson for Clinical Trial matching system.  The Watson system uses artificial intelligence to analyze unstructured information and pull out insights from the data.  “Watson is able to give us faster, better matching of patients to...
By Jonah Comstock March 6, 2018
Artificial intelligence has huge potential to transform care, but the healthcare system needs to walk before it can run, according to a panel of speakers from IBM Watson, the Mayo Clinic, and the American Medical Association at an after hours dinner at HIMSS18 Monday. “I think this AI stuff is absolutely real, but at the same time we haven’t finished the first job, which is creating systems that...
By Dave Muoio February 28, 2018
Correction: A previous version of this article misstated Watson's contributions to the Teladoc platform. Watson does not offer diagnoses. With the acquisition of Best Doctors last summer, telemedicine vendor Teladoc has been providing specialist consultations through its remote platform. A less-publicized outcome of the deal, however, is that the company has also absorbed and implemented the...
By Jonah Comstock December 7, 2017
Alder Hey Children's Hospital in Liverpool, UK has launched a new augmented reality tablet app for children to entertain, educate, and distract the hospital's young children. In Alder Play, available on iOS and Android, children can choose an animated avatar who will appear on the app as they visit different parts of the hospital and offer them entertainment, information, and support, as well as...
By Dave Muoio December 5, 2017
Last week, hundreds of digital health entrepreneurs, investors, and executives met in Boston for the annual Digital Healthcare Innovation Summit. Among the more frequently discussed trends and technologies was artificial intelligence — its promise, its stumbles, and how it should be implemented to best serve healthcare. “I started marketing Watson for Oncology in January of 2016. I’m almost...
By Jonah Comstock September 6, 2017
Questions raised about IBM Watson for Oncology. A new report from STAT suggests that IBM has been overpromising and underdelivering with the cancer treatment application of its artificial intelligence engine. The article points out a lack of independent, peer-reviewed studies validating the software, and charges that Watson "doesn’t create new knowledge and is artificially intelligent only in the...
By Heather Mack July 6, 2017
San Francisco-based Mendel.ai, a startup that is developing an artificial intelligence-powered platform to match people with cancer to clinical trials, has raised $2 million in seed funding from DCM Ventures, BootstrapLabs, Indie Bio, LaunchCapital and SOSV. Medel.ai will use the capital to forge partnerships with hospitals and cancer genomics companies to bring the system into use. For $99,...
By Heather Mack June 8, 2017
Novartis and IBM Watson are working together on a new initiative to improve cancer care. In what the pharmaceutical company called a “first-of-its-kind collaboration, the two will use IBM Watson’s cognitive computing tools to leverage Novartis’s portfolio of breast cancer compounds and real-world patient data. The goal is to use data analytics and machine learning to determine which combinations...